山西医药杂志
山西醫藥雜誌
산서의약잡지
SHANXI MEDICAL JOURNAL
2014年
17期
2007-2009
,共3页
蒋莹辉%尚文英%支忠继%曹西田%王欣%赵晓%镡红印
蔣瑩輝%尚文英%支忠繼%曹西田%王訢%趙曉%鐔紅印
장형휘%상문영%지충계%조서전%왕흔%조효%심홍인
肾小球硬化症, 病灶性%转化生长因子β%脂蛋白, LDL%脂蛋白(A)
腎小毬硬化癥, 病竈性%轉化生長因子β%脂蛋白, LDL%脂蛋白(A)
신소구경화증, 병조성%전화생장인자β%지단백, LDL%지단백(A)
Glomerulosclerosis,focal%Transforming growth factor beta%Lipoproteins,LDL%Lipo-protein(a)
目的:探讨特发性难治性局灶节段性肾小球硬化(FSGS)患者脂蛋白a[Lp(a)]、低密度脂蛋白胆固醇(LDL-C)、转化生长因子β1(TGF-β1)水平与疗效的相关性。方法回顾性分析134例特发性FSGS患者,根据治疗4个月时尿蛋白定量、肾功能及血清白蛋白情况分为难治组64例和激素敏感组70例,分析足量激素治疗前,治疗2、4、6个月时血清胆固醇(CHO)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、LDL-C、Lp(a)和TGF-β1水平。结果特发性FSGS难治组和FSGS激素敏感组的血清Lp(a)、TGF-β1、LDL-C均明显高于正常范围,难治组Lp(a)和TGF-β1高于激素敏感组,差异有统计学意义( P <0.05);难治组LDL-C较激素敏感组升高,但差异无统计学意义( P >0.05)。经足量激素治疗4个月后,激素敏感组Lp(a)、TGF-β1、LDL-C较治疗前均明显下降,差异有统计学意义( P <0.05)。难治组Lp(a)、TGF-β1、LDL-C较治疗前无明显变化,差异无统计学意义( P >0.05)。结论特发性FSGS存在Lp(a)、TGF-β1的代谢紊乱,同时其升高程度可作为特发性难治性FSGS早期判定指标,早期联合其他治疗方案,减少激素不良反应。
目的:探討特髮性難治性跼竈節段性腎小毬硬化(FSGS)患者脂蛋白a[Lp(a)]、低密度脂蛋白膽固醇(LDL-C)、轉化生長因子β1(TGF-β1)水平與療效的相關性。方法迴顧性分析134例特髮性FSGS患者,根據治療4箇月時尿蛋白定量、腎功能及血清白蛋白情況分為難治組64例和激素敏感組70例,分析足量激素治療前,治療2、4、6箇月時血清膽固醇(CHO)、甘油三酯(TG)、高密度脂蛋白膽固醇(HDL-C)、LDL-C、Lp(a)和TGF-β1水平。結果特髮性FSGS難治組和FSGS激素敏感組的血清Lp(a)、TGF-β1、LDL-C均明顯高于正常範圍,難治組Lp(a)和TGF-β1高于激素敏感組,差異有統計學意義( P <0.05);難治組LDL-C較激素敏感組升高,但差異無統計學意義( P >0.05)。經足量激素治療4箇月後,激素敏感組Lp(a)、TGF-β1、LDL-C較治療前均明顯下降,差異有統計學意義( P <0.05)。難治組Lp(a)、TGF-β1、LDL-C較治療前無明顯變化,差異無統計學意義( P >0.05)。結論特髮性FSGS存在Lp(a)、TGF-β1的代謝紊亂,同時其升高程度可作為特髮性難治性FSGS早期判定指標,早期聯閤其他治療方案,減少激素不良反應。
목적:탐토특발성난치성국조절단성신소구경화(FSGS)환자지단백a[Lp(a)]、저밀도지단백담고순(LDL-C)、전화생장인자β1(TGF-β1)수평여료효적상관성。방법회고성분석134례특발성FSGS환자,근거치료4개월시뇨단백정량、신공능급혈청백단백정황분위난치조64례화격소민감조70례,분석족량격소치료전,치료2、4、6개월시혈청담고순(CHO)、감유삼지(TG)、고밀도지단백담고순(HDL-C)、LDL-C、Lp(a)화TGF-β1수평。결과특발성FSGS난치조화FSGS격소민감조적혈청Lp(a)、TGF-β1、LDL-C균명현고우정상범위,난치조Lp(a)화TGF-β1고우격소민감조,차이유통계학의의( P <0.05);난치조LDL-C교격소민감조승고,단차이무통계학의의( P >0.05)。경족량격소치료4개월후,격소민감조Lp(a)、TGF-β1、LDL-C교치료전균명현하강,차이유통계학의의( P <0.05)。난치조Lp(a)、TGF-β1、LDL-C교치료전무명현변화,차이무통계학의의( P >0.05)。결론특발성FSGS존재Lp(a)、TGF-β1적대사문란,동시기승고정도가작위특발성난치성FSGS조기판정지표,조기연합기타치료방안,감소격소불량반응。
Objective To investigate the relationship between plasma transforming growth factor-β1 (TGF-β1 ) ,low density lipoprotein cholesterol (LDL-C)and lipoprotein(a) [Lp(a)] in focal segmental glomerulosclerosis (FSGS) .Meth-ods A total of 134 patients were enrolled in this cross-sectional study .According to urinary protein ,renal function and plasma protein after enough prednisone treatment for 4 months ,patients were divided into 64 cases as difficulty group and 70 cases as sensitive group .Level of TGF-β1 ,LDL-C and Lp(a) were analyzed before and 2 ,4 ,6 months after treatment among different groups. Results Level of plasma Lp(a) ,TGF-β1 and LDL-C were higher than normal in both groups . Lp(a)and TGF-β1 in difficulty group were higher than those in sensitive group ( P<0 .05) .Level of plasma LDL-C was not significant ( P>0 .05) .After treatment with enough prednisone for 4 months ,Lp(a) ,TGF-β1 and LDL-C were lower in sensitive group than before ( P<0 .05) .Another group was not significant ( P>0 .05) .Conclusion Level of plasma Lp(a) ,TGF-β1 was disordered in FSGS .They can be used as early marker in difficulty group.